Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers

PHASE3UnknownINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Chronic Venous Leg Ulcers
Interventions
BIOLOGICAL

CureXcell®

CureXcell® is a cell based therapy obtained from donated whole blood. The blood is collected from healthy young adults, the white blood cells are separated and then activated by hypo-osmotic shock.

OTHER

Placebo injection

Normal saline injected at each centimeter of ulcer bed

Trial Locations (28)

Unknown

Mesa

Phoenix

Carlsbad

Castro Valley

Fresno

Laguna Hills

Los Angeles

San Francisco

Sylmar

Hialeah

Miami

South Miami

Chicago

Oak Park

Indianapolis

Baltimore

Boston

Las Vegas

Emerson

Summit

Toms River

New York

Chapel Hill

Willoughby

Wyomissing

Dallas

Lewisville

McAllen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Macrocure Ltd.

INDUSTRY

NCT02130310 - Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers | Biotech Hunter | Biotech Hunter